| 1 |
27769058 | Bortezomib-resistance is associated with increased levels of proteasome subunits and apoptosis-avoidance. | 2016 Nov 22 |
1 |
| 2 |
25742740 | Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells. | 2015 May |
1 |
| 3 |
23383345 | Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome. | 2013 |
2 |
| 4 |
21393428 | Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A. | 2011 May |
1 |
| 5 |
20478922 | G(alpha)12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulation. | 2010 Jul |
2 |
| 6 |
20729919 | CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. | 2010 Nov 25 |
1 |
| 7 |
19261616 | Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway. | 2009 Apr 24 |
1 |
| 8 |
18701494 | Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells. | 2008 Aug 15 |
3 |